Armstrong, A., Paul, C., Puig, L., Boehncke, W., Freeman, M., Torii, H., . . . Lebwohl, M. (2020). Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.
Citación estilo ChicagoArmstrong, A., et al. Safety of Ixekizumab Treatment for Up to 5 Years in Adult Patients With Moderate-to-Severe Psoriasis: Results From Greater Than 17,000 Patient-Years of Exposure. 2020.
Cita MLAArmstrong, A., et al. Safety of Ixekizumab Treatment for Up to 5 Years in Adult Patients With Moderate-to-Severe Psoriasis: Results From Greater Than 17,000 Patient-Years of Exposure. 2020.
Precaución: Estas citas no son 100% exactas.